Leon David, Parada Daniela, Vargas-Uribe Mauricio, Perez Alejandra A, Ojeda Lorena, Zambrano Angara, Reyes Alejandro M, Salas Mónica
Facultad de Ciencias Instituto de Bioquímica y Microbiología Universidad Austral de Chile Valdivia Chile.
FEBS Open Bio. 2016 Aug 23;6(10):1000-1007. doi: 10.1002/2211-5463.12106. eCollection 2016 Oct.
The polyphenol nordihydroguaiaretic acid (NDGA) has antineoplastic properties, hence it is critical to understand its action at the molecular level. Here, we establish that NDGA inhibits glucose uptake and cell viability in leukemic HL-60 and U-937 cell lines. We monitored hexose uptake using radio-labeled 2-deoxyglucose (2DG) and found that the inhibition by NDGA followed a noncompetitive mechanism. In addition, NDGA blocked hexose transport in human red blood cells and displaced prebound cytochalasin B from erythrocyte ghosts, suggesting a direct interaction with the glucose transporter GLUT1. We propose a model for the mechanism of action of NDGA on glucose uptake. Our study shows for the first time that NDGA can act as inhibitor of the glucose transporter GLUT1.
多酚去甲二氢愈创木酸(NDGA)具有抗肿瘤特性,因此了解其在分子水平的作用至关重要。在此,我们证实NDGA可抑制白血病HL-60和U-937细胞系中的葡萄糖摄取及细胞活力。我们使用放射性标记的2-脱氧葡萄糖(2DG)监测己糖摄取,发现NDGA的抑制作用遵循非竞争性机制。此外,NDGA阻断了人类红细胞中的己糖转运,并将预先结合的细胞松弛素B从红细胞血影中置换出来,提示其与葡萄糖转运蛋白GLUT1存在直接相互作用。我们提出了一个NDGA对葡萄糖摄取作用机制的模型。我们的研究首次表明NDGA可作为葡萄糖转运蛋白GLUT1的抑制剂。